NYSE:HUM - Humana Stock Price, Price Target & More

$294.55 -2.84 (-0.95 %)

(As of 04/26/2018 01:31 PM ET)

Previous Close$297.39

Today's Range$293.50 - $298.25

52-Week Range$217.83 - $299.67

Volume168,705 shs

Average Volume1.04 million shs

Market Capitalization$40.47 billion

P/E Ratio25.16

Dividend Yield0.68%

Beta0.97

About Humana (NYSE:HUM)

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans

Sub-IndustryManaged Health Care

SectorMedical

SymbolNYSE:HUM

CUSIP44485910

Webwww.humana.com

Phone502-580-1000

Debt

Debt-to-Equity Ratio0.48%

Current Ratio1.85%

Quick Ratio1.85%

Price-To-Earnings

Trailing P/E Ratio25.16

Forward P/E Ratio21.22

P/E Growth1.59

Sales & Book Value

Annual Sales$53.77 billion

Price / Sales0.75

Cash Flow$15.3652 per share

Price / Cash19.17

Book Value$68.89 per share

Price / Book4.28

Profitability

EPS (Most Recent Fiscal Year)$11.71

Net Income$2.45 billion

Net Margins4.55%

Return on Equity16.13%

Return on Assets5.49%

Miscellaneous

Employees45,900

Outstanding Shares137,680,000

How to Become a New Pot Stock Millionaire

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Thursday, April 19th. Stockholders of record on Friday, June 29th will be paid a dividend of $0.50 per share on Friday, July 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Thursday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has initiated a share repurchase program on Friday, December 15th 2017, which permits the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's board believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana (NYSE:HUM) issued its earnings results on Wednesday, February, 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.00 by $0.06. The insurance provider had revenue of $13.19 billion for the quarter, compared to analysts' expectations of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The company's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.34 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana updated its FY18 earnings guidance on Thursday, March, 1st. The company provided EPS guidance of $13.40-14.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.86.

What price target have analysts set for HUM?

17 brokerages have issued 12-month target prices for Humana's stock. Their predictions range from $221.00 to $330.00. On average, they expect Humana's stock price to reach $276.9412 in the next twelve months. View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

1. Cantor Fitzgerald analysts commented, "This morning, Humana announced it would acquire a 40% interest in Curo Health Services, a large, privately-held hospice company." (4/23/2018)
2. According to Zacks Investment Research, "Humana’s shares have outperformed the industry year to date. The company is well poised to grow on its strong government business. Its top line has been witnessing an uptrend for past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remain major tailwinds. Following decent 2017 results, the company provided strong guidance for 2018. However, the company's individual commercial business has remained a drag over past few years. Rising level of expenses also continues to weigh on the bottom line." (4/13/2018)

Who are some of Humana's key competitors?

Some companies that are related to Humana include Aetna (AET), Anthem (ANTM), Cigna (CI), Centene (CNC), WellCare (WCG), Molina Healthcare (MOH), Trupanion (TRUP) and Comprehensive Care (CHCR).

Who are Humana's key executives?

Humana's management team includes the folowing people:

Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
Mr. Timothy S. Huval, Chief HR Officer (Age 52)
Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Mr. James Elmer Murray, Advisor (Age 64)

Has Humana been receiving favorable news coverage?

News articles about HUM stock have been trending somewhat negative this week, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Humana earned a media sentiment score of -0.10 on Accern's scale. They also gave news coverage about the insurance provider an impact score of 47.60 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $294.55.

How big of a company is Humana?

Humana has a market capitalization of $40.47 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.

MarketBeat Community Rating for Humana (HUM)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		599 (Vote Outperform)
Underperform Votes:		683 (Vote Underperform)
Total Votes:		1,282

MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Humana (NYSE:HUM) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

17 Wall Street analysts have issued ratings and price targets for Humana in the last 12 months. Their average twelve-month price target is $276.9412, suggesting that the stock has a possible downside of 5.98%. The high price target for HUM is $330.00 and the low price target for HUM is $221.00. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.71	2.74	2.68	2.57
Ratings Breakdown:	0 Sell Rating(s) 5 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 14 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$276.9412	$269.1667	$260.8333	$252.95
Price Target Upside:	5.98% downside	1.45% upside	1.65% downside	6.65% upside

Humana (NYSE:HUM) Consensus Price Target History

Price Target History for Humana (NYSE:HUM)

Humana (NYSE:HUM) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/23/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$250.00	High
4/16/2018	Argus	Boost Price Target	Buy -> Buy	$270.00 -> $330.00	Low
4/4/2018	Piper Jaffray	Reiterated Rating	Buy	$313.00	Low
2/12/2018	JPMorgan Chase	Boost Price Target	Neutral -> Neutral	$253.00 -> $271.00	Low
2/9/2018	Deutsche Bank	Boost Price Target	Hold -> Hold	$259.00 -> $270.00	Low
2/8/2018	Oppenheimer	Boost Price Target	Outperform	$275.00 -> $305.00	Medium
2/8/2018	Leerink Swann	Boost Price Target	Outperform -> Outperform	$280.00 -> $300.00	High
2/8/2018	Credit Suisse Group	Upgrade	Neutral -> Outperform	$264.90 -> $246.00	Medium
1/12/2018	Jefferies Group	Upgrade	Hold -> Buy	$221.00	Medium
1/3/2018	Goldman Sachs	Initiated Coverage	Buy -> Buy	$305.00	Low
12/13/2017	Cowen	Reiterated Rating	Buy	$285.00	Low
11/10/2017	BMO Capital Markets	Boost Price Target	Outperform	$290.00 -> $300.00	N/A
11/9/2017	Morgan Stanley	Lower Price Target	Overweight	$276.00 -> $270.00	N/A
11/9/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform -> Sector Perform	$245.00 -> $242.00	N/A
8/9/2017	UBS	Reiterated Rating	Neutral	$237.00 -> $250.00	Low
7/14/2017	Bank of America	Boost Price Target	Buy	$270.00 -> $275.00	Low
6/28/2017	Citigroup	Initiated Coverage	Buy -> Buy	$275.00	Medium
4/25/2017	Evercore ISI	Reiterated Rating	Outperform	$240.00	Low
3/30/2017	CIBC	Reiterated Rating	Outperform		Low
1/24/2017	Stifel Nicolaus	Downgrade	Buy -> Hold	$214.00 -> $210.00	N/A
1/9/2017	Barclays	Reiterated Rating	Hold	$217.00	N/A
12/4/2016	Susquehanna Bancshares	Reiterated Rating	Neutral	$180.00 -> $200.00	N/A
7/22/2016	FBR & Co	Lower Price Target	Mkt Perform	$220.00 -> $170.00	N/A
7/21/2016	Wolfe Research	Upgrade	Outperform	$192.00	N/A

(Data available from 4/26/2016 forward)

Humana (NYSE:HUM) Earnings History and Estimates Chart

Earnings by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Earnings Estimates

2018 EPS Consensus Estimate: $13.93
2019 EPS Consensus Estimate: $16.49

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$3.18	$3.21	$3.20
Q2 2018	3	$4.00	$4.13	$4.08
Q3 2018	3	$3.96	$4.04	$4.00
Q4 2018	3	$2.44	$2.83	$2.65
Q1 2019	1	$3.82	$3.82	$3.82
Q2 2019	1	$4.91	$4.91	$4.91
Q3 2019	1	$4.77	$4.77	$4.77
Q4 2019	1	$2.99	$2.99	$2.99

Humana (NYSE HUM) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018		$3.08					N/A
2/7/2018	Q4 2017	$2.00	$2.06	$13.1374 billion	$13.1890 billion	View	Listen
11/8/2017	Q3 2017	$3.27	$3.39	$13.4130 billion	$13.2820 billion	View	N/A
8/2/2017	Q2 2017	$3.08	$3.49	$13.6117 billion	$13.5340 billion	View	Listen
5/3/2017	Q1 2017	$2.55	$2.75	$13.6104 billion	$13.7620 billion	View	N/A
2/8/2017	Q416	$2.05	$2.09	$13.55 billion	$12.88 billion	View	N/A
11/4/2016	Q316	$3.09	$3.18	$13.41 billion	$13.69 billion	View	N/A
8/3/2016	Q216	$2.23	$2.30	$13.59 billion	$14.00 billion	View	N/A
5/4/2016	Q1	$1.81	$1.86	$13.8024 billion	$13.80 billion	View	N/A
2/10/2016	Q415	$1.45	$1.45	$13.51 billion	$13.40 million	View	N/A
11/6/2015	Q315	$2.13	$2.16	$13.64 billion	$13.3630 billion	View	N/A
7/29/2015	Q215	$1.63	$1.67	$13.81 billion	$13.73 billion	View	N/A
4/29/2015	Q115	$2.54	$2.47	$13.51 billion	$13.80 billion	View	Listen
2/4/2015	Q414	$1.16	$1.09	$12.41 billion	$12.23 million	View	Listen
11/7/2014	Q314	$2.01	$1.85	$12.34 billion	$12.2380 billion	View	Listen
7/30/2014	Q214	$2.19	$2.19	$11.9317 billion	$12.2220 billion	View	Listen
5/7/2014	Q114	$1.94	$2.35	$11.4451 billion	$11.7120 billion	View	Listen
2/5/2014	Q413	$0.95	($0.19)	$10.23 billion	$10.20 billion	View	Listen
11/6/2013	Q313	$2.14	$2.31	$10.27 billion	$10.00 billion	View	Listen
7/31/2013	Q2 2013	$2.46	$2.63	$10.36 billion	$10.32 billion	View	Listen
5/1/2013	Q1 2013	$1.80	$2.95	$10.23 billion	$10.49 billion	View	Listen
2/4/2013	Q4 2012	$1.07	$1.19	$9.73 billion	$9.56 billion	View	Listen
11/5/2012	Q312	$2.05	$2.62	$9.86 billion	$9.6510 billion	View	N/A
7/30/2012		$2.21	$2.16			View	N/A
4/30/2012		$1.54	$1.49			View	N/A
2/6/2012		$1.20	$1.20			View	N/A
10/31/2011		$2.03	$2.54			View	N/A
8/1/2011		$2.05	$2.50			View	N/A
5/2/2011		$1.86	$1.86			View	N/A
2/7/2011		$0.81	$0.63			View	N/A
11/1/2010	Q3 2010	$1.67	$2.01			View	N/A
8/2/2010	Q2 2010	$1.63	$2.11			View	N/A
4/26/2010	Q1 2010	$1.15	$1.20			View	N/A
2/1/2010	Q4 2009	$1.48	$1.48			View	N/A
11/2/2009	Q3 2009	$1.78	$1.78			View	N/A
8/3/2009	Q2 2009	$1.65	$1.67			View	N/A
4/27/2009	Q1 2009	$1.14	$1.22			View	N/A
2/2/2009	Q4 2008	$1.07	$1.07			View	N/A
10/27/2008	Q3 2008	$1.46	$1.48			View	N/A
8/4/2008	Q2 2008	$1.18	$1.24			View	N/A
4/28/2008	Q1 2008	$0.45	$0.47			View	N/A
2/4/2008	Q4 2007	$1.32	$1.43			View	N/A

(Earnings results data provided by Zacks Investment Research)

Humana (NYSE:HUM) Dividend Information

Humana pays an annual dividend of $2.00 per share, with a dividend yield of 0.68%. HUM's next quarterly dividend payment will be made on Friday, July 27. The company has grown its dividend for the last 7 consecutive years and is increasing its dividend by an average of 10.60% each year. Humana pays out 17.08% of its earnings out as a dividend.

Next Dividend:	7/27/2018
Annual Dividend:	$2.00
Dividend Yield:	0.68%
Dividend Growth:	10.60% (3 Year Average)
Payout Ratio:	17.08% (Trailing 12 Months of Earnings) 14.41% (Based on This Year's Estimates) 12.08% (Based on Next Year's Estimates)
Track Record:	7 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/19/2018	quarterly	$0.50	0.68%	6/28/2018	6/29/2018	7/27/2018
2/6/2018	Quarterly	$0.50	0.74%	3/28/2018	3/30/2018	4/27/2018
11/2/2017	quarterly	$0.40	0.62%	12/28/2017	12/29/2017	1/26/2018
8/17/2017		$0.40		9/28/2017	9/29/2017	10/16/2017
8/17/2017	quarterly	$0.40	0.65%	9/28/2017	8/29/2017	10/27/2017
4/20/2017	quarterly	$0.40	0.75%	6/28/2017	6/30/2017	7/31/2017
2/15/2017	quarterly	$0.40	0.78%	3/29/2017	3/31/2017	4/28/2017
10/26/2016	quarterly	$0.29	0.67%	1/10/2017	1/12/2017	1/27/2017
8/25/2016	quarterly	$0.29	0.65%	10/11/2016	10/13/2016	10/28/2016
4/21/2016	quarterly	$0.29	0.66%	6/28/2016	6/30/2016	7/29/2016
2/18/2016	quarterly	$0.29	0.7%	3/29/2016	3/31/2016	4/29/2016
10/29/2015	quarterly	$0.29	0.65%	12/28/2015	12/30/2015	1/29/2016
8/27/2015	quarterly	$0.29	0.63%	9/28/2015	9/30/2015	10/30/2015
4/17/2015	quarterly	$0.29	0.65%	6/26/2015	6/30/2015	7/31/2015
2/18/2015	quarterly	$0.28	0.73%	3/27/2015	3/31/2015	4/24/2015
10/31/2014	quarterly	$0.28	0.81%	12/29/2014	12/31/2014	1/30/2015
8/27/2014	quarterly	$0.28	0.88%	9/26/2014	9/30/2014	10/31/2014
4/30/2014	quarterly	$0.28	1.02%	6/26/2014	6/30/2014	7/25/2014
2/19/2014	quarterly	$0.27	1.06%	3/27/2014	3/31/2014	4/25/2014
10/30/2013	quarterly	$0.27	1.17%	12/27/2013	12/31/2013	1/31/2014
8/22/2013	quarterly	$0.27	1.14%	9/26/2013	9/30/2013	10/25/2013
4/25/2013	quarterly	$0.27	1.47%	6/26/2013	6/28/2013	7/26/2013
2/27/2013	quarterly	$0.26	1.52%	3/26/2013	3/28/2013	4/26/2013

(Data available from 1/1/2013 forward)

Humana (NYSE HUM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.60%
Institutional Ownership Percentage: 96.58%

Insider Trading History for Humana (NYSE:HUM)

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2018	Cynthia H Zipperle	SVP	Sell	1,196	$273.33	$326,902.68	7,771
2/27/2018	M Todoroff Christopher	Insider	Sell	16,389	$273.37	$4,480,260.93	13,447
2/26/2018	Bruce D Broussard	CEO	Sell	14,075	$274.32	$3,861,054.00	113,896
12/21/2017	Brian P Leclaire	SVP	Sell	1,679	$245.97	$412,983.63	9,888
12/19/2017	Timothy S Huval	VP	Sell	1,382	$246.04	$340,027.28	11,557
12/18/2017	Jody L Bilney	SVP	Sell	7,054	$247.89	$1,748,616.06	11,704
9/1/2017	Elizabeth D Bierbower	Insider	Sell	9,786	$259.00	$2,534,574.00	18,042
9/1/2017	Timothy S Huval	VP	Sell	7,803	$258.14	$2,014,266.42	8,831
8/23/2017	William Kevin Fleming	Insider	Sell	3,071	$250.98	$770,759.58	7,681
8/11/2017	Bruce D Broussard	CEO	Sell	12,000	$251.88	$3,022,560.00	80,086
8/10/2017	M Todoroff Christopher	VP	Sell	22,935	$252.52	$5,791,546.20	24,001
6/28/2017	Brian P Leclaire	SVP	Sell	4,971	$240.00	$1,193,040.00	14,258
5/26/2017	Heidi S Margulis	VP	Sell	1,500	$231.96	$347,940.00	8,150
5/5/2017	Jody L Bilney	SVP	Sell	4,600	$230.16	$1,058,736.00	8,978
5/4/2017	Bruce D Broussard	CEO	Sell	118,231	$225.82	$26,698,924.42	171,170
5/4/2017	Timothy S Huval	VP	Sell	13,939	$225.86	$3,148,262.54	23,639
3/21/2017	Jody L Bilney	SVP	Sell	4,348	$213.80	$929,602.40	13,578
3/6/2017	James E Murray	COO	Sell	31,151	$213.62	$6,654,476.62	45,635
3/3/2017	Cynthia H Zipperle	VP	Sell	1,885	$213.37	$402,202.45	3,736
2/24/2017	Brian P Leclaire	SVP	Sell	4,971	$204.81	$1,018,110.51	14,258
2/22/2017	Brian P Leclaire	SVP	Sell	26,894	$205.24	$5,519,724.56	25,734
2/22/2017	James E Murray	COO	Sell	9,523	$204.69	$1,949,262.87	76,798
2/22/2017	Roy A Beveridge	VP	Sell	4,832	$205.73	$994,087.36	18,439
2/21/2017	Bruce D Broussard	CEO	Sell	104,256	$205.23	$21,396,458.88	155,108
2/21/2017	Cynthia H Zipperle	CAO	Sell	4,213	$204.67	$862,274.71	6,542
2/21/2017	David A. Jr/Ky Jones	Director	Sell	27,000	$205.04	$5,536,080.00
2/21/2017	James E Murray	COO	Sell	70,332	$205.20	$14,432,126.40	76,798
2/21/2017	Jody L Bilney	SVP	Sell	6,087	$204.72	$1,246,130.64	28,577
2/21/2017	M Todoroff Christopher	VP	Sell	24,140	$205.33	$4,956,666.20
2/25/2016	Brian P Leclaire	SVP	Sell	183	$176.11	$32,228.13	17,301
3/11/2015	James E Murray	COO	Sell	35,220	$160.90	$5,666,898.00
3/2/2015	Brian P Leclaire	SVP	Sell	5,500	$161.79	$889,845.00
2/25/2015	Bruce D Broussard	CEO	Sell	41,105	$165.29	$6,794,245.45
2/25/2015	David A Jr/Ky Jones	Director	Sell	6,100	$165.39	$1,008,879.00
2/24/2015	Heidi S Margulis	VP	Sell	3,665	$164.44	$602,672.60
8/22/2014	Brian P Leclaire	SVP	Sell	3,250	$123.04	$399,880.00
5/15/2014	Heidi Margulis	VP	Sell	3,345	$119.56	$399,928.20	8,730
5/12/2014	Marissa Peterson	Director	Sell	2,026	$123.30	$249,805.80	1,358
3/19/2014	James Murray	COO	Sell	36,833	$116.59	$4,294,359.47	89,892
3/18/2014	M Todoroff Christopher	VP	Sell	8,000	$113.20	$905,600.00	18,225
3/13/2014	Bruce Broussard	CEO	Sell	109,000	$109.84	$11,972,560.00	59,944
3/10/2014	Webster Roy Dunbar	Director	Sell	9,587	$110.30	$1,057,446.10	1,458
12/4/2013	Marissa Peterson	Director	Sell	1,147	$103.54	$118,760.38
12/2/2013	M Todoroff Christopher	VP	Sell	6,000	$105.50	$633,000.00	16,226
11/26/2013	Heidi Margulis	VP	Sell	5,500	$104.42	$574,310.00	7,136
11/8/2013	David Jr/Ky Jones	Director	Sell	11,000	$95.00	$1,045,000.00	143,339
9/5/2013	Elizabeth D Bierbower	Insider	Sell	17,673	$96.01	$1,696,784.73
8/30/2013	Heidi Margulis	VP	Sell	3,319	$93.35	$309,828.65	10,801
8/29/2013	David Jr/Ky Jones	Director	Sell	2,500	$93.01	$232,525.00	154,339
8/23/2013	Elizabeth Bierbower	Insider	Sell	6,063	$94.00	$569,922.00	16,473
8/15/2013	Michael Mccallister	Director	Sell	138,817	$91.49	$12,700,367.33	111,859
8/13/2013	Bruce Perkins	Insider	Sell	9,000	$93.47	$841,230.00	10,985
8/8/2013	Steven Mcculley	VP	Sell	10,000	$92.54	$925,400.00	9,327
8/7/2013	James Bloem	CFO	Sell	33,000	$91.79	$3,029,070.00	21,767
8/1/2013	M Todoroff Christopher	VP	Sell	39,596	$90.30	$3,575,518.80
6/24/2013	Paul B K Kusserow	SVP	Sell	34,219	$84.60	$2,894,927.40
6/18/2013	Elizabeth D Bierbower	Insider	Sell	8,033	$83.29	$669,068.57
5/30/2013	James E Murray	COO	Sell	11,000	$81.96	$901,560.00
5/9/2013	Michael B Mccallister	Director	Sell	281,312	$77.72	$21,863,568.64

(Data available from 1/1/2013 forward)

Humana (NYSE HUM) News Headlines

Source:

Date	Headline
	At $293.95, Is Humana Inc (NYSE:HUM) A Buy? finance.yahoo.com - April 26 at 9:19 AM
	Zacks: Analysts Expect Humana (HUM) Will Announce Earnings of $3.21 Per Share www.americanbankingnews.com - April 25 at 9:24 PM
	Humana (HUM) to Release Earnings on Wednesday www.americanbankingnews.com - April 25 at 2:38 AM
	BRIEF-Humana and Landmark Announce In-Home Care Program for Humana Medicare Advantage Members www.reuters.com - April 24 at 4:28 PM
	Humana's deal for Curo Health debunks Walmart takeover, analyst says www.bizjournals.com - April 24 at 4:28 PM
	UNH’s Optum Business Posted 11.1% Revenue Growth in 1Q18 finance.yahoo.com - April 24 at 9:21 AM
	BRIEF-Humana, Together With TPG Capital And Welsh, Carson, Anderson & Stowe, Announce Agreement To Acquire ... www.reuters.com - April 23 at 9:41 AM
	Humana (HUM) Stock Rating Reaffirmed by Cantor Fitzgerald www.americanbankingnews.com - April 23 at 9:18 AM
	Cantor Fitzgerald Reiterates Neutral Rating for Humana (HUM) www.americanbankingnews.com - April 20 at 4:17 PM
	UBS Reaffirms Neutral Rating for Humana (HUM) www.americanbankingnews.com - April 20 at 11:32 AM
	Philanthropy roundup: Xcenda, Humana and more www.bizjournals.com - April 20 at 9:37 AM
	BRIEF-Humana Inc Sets Quarterly Cash Dividend Of $0.50 Per Share www.reuters.com - April 20 at 9:37 AM
	Humana AB (STO:HUM): Time For A Financial Health Check finance.yahoo.com - April 20 at 9:37 AM
	Humana (HUM) Declares Quarterly Dividend of $0.50 www.americanbankingnews.com - April 19 at 5:36 PM
	Humana Board Declares Payment of Quarterly Dividend to Stockholders finance.yahoo.com - April 19 at 4:40 PM
	Zacks Investment Research Lowers Humana (HUM) to Hold www.americanbankingnews.com - April 17 at 5:25 PM
	The Long-Term Bull Driving Humana Is Back With New Price Targets finance.yahoo.com - April 17 at 9:33 AM
	Analyzing UNH Stock’s Recent Performance finance.yahoo.com - April 17 at 9:33 AM
	Humana (HUM) Expected to Earn Q1 2018 Earnings of $3.21 Per Share www.americanbankingnews.com - April 17 at 6:45 AM
	Humana (HUM) PT Raised to $330 at Argus www.streetinsider.com - April 16 at 9:38 AM
	Humana (HUM) Price Target Raised to $330.00 www.americanbankingnews.com - April 16 at 9:16 AM
	Humana (HUM) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - April 15 at 5:06 PM
	Humana (HUM) Given Average Rating of "Buy" by Analysts www.americanbankingnews.com - April 15 at 5:45 AM
	Humana (HUM) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 14 at 10:53 PM
	Humana (HUM) Price Target Raised to $280.00 at Piper Jaffray www.americanbankingnews.com - April 13 at 7:49 PM
	Oppenheimer Increases Humana (HUM) Price Target to $255.00 www.americanbankingnews.com - April 13 at 5:29 PM
	Humana (HUM) Upgraded to Buy at Zacks Investment Research www.americanbankingnews.com - April 13 at 11:12 AM
	FY2019 EPS Estimates for Humana (HUM) Raised by Analyst www.americanbankingnews.com - April 13 at 9:45 AM
	Humana Expands Availability of Value-Based Orthopedic Specialty Care to Improve Patient Experience in Seven ... www.businesswire.com - April 12 at 4:37 PM
	5 Ways A Walmart-Humana Partnership Could Change Everyone's In-Store Experience www.forbes.com - April 12 at 4:37 PM
	Humana Expands Availability of Value-Based Orthopedic Specialty Care to Improve Patient Experience in Seven Additional States finance.yahoo.com - April 12 at 10:12 AM
	Humana expands Medicare business with acquisition of physicians group www.bizjournals.com - April 11 at 4:35 PM
	Humana (HUM) Shores Up Government Business With FPG Buyout finance.yahoo.com - April 11 at 4:34 PM
	Humana Buys More Doctor Practices Amid Walmart Speculation finance.yahoo.com - April 11 at 10:02 AM
	Humana acquires Florida family physician group seekingalpha.com - April 11 at 12:31 AM
	Humana (HUM) Upgraded by BidaskClub to "Hold" www.americanbankingnews.com - April 10 at 9:26 PM
	BRIEF-Humana Acquires Family Physicians Group In Central Florida www.reuters.com - April 10 at 4:32 PM
	Humana Acquires Family Physicians Group in Central Florida finance.yahoo.com - April 10 at 4:32 PM
	Humana (HUM) Expected to Post Quarterly Sales of $14.12 Billion www.americanbankingnews.com - April 10 at 2:17 AM
	Humana (HUM) Lifted to Hold at BidaskClub www.americanbankingnews.com - April 9 at 10:19 PM
	Zacks: Analysts Expect Humana (HUM) to Announce $3.21 Earnings Per Share www.americanbankingnews.com - April 8 at 9:14 PM
	Humana (HUM) Stock Rating Lowered by JPMorgan Chase www.americanbankingnews.com - April 7 at 8:50 PM
	Humana (HUM) Cut to "Hold" at ValuEngine www.americanbankingnews.com - April 7 at 8:50 PM
	Humana (HUM) Given Hold Rating at Royal Bank of Canada www.americanbankingnews.com - April 7 at 7:47 PM
	Humana (HUM) Rating Reiterated by Piper Jaffray www.americanbankingnews.com - April 4 at 6:26 AM
	Humana (HUM) Raised to Buy at ValuEngine www.americanbankingnews.com - April 3 at 1:55 PM
	The Biggest Movers: Humana Jumps, Nektar Tumbles www.barrons.com - April 3 at 9:36 AM
	Humana Deal Could Bring Walmart Into Patient Homes For Care www.forbes.com - April 3 at 9:36 AM
	Stock market kicks off April trade mostly lower; Humana's stock jumps on report of Walmart interest www.marketwatch.com - April 2 at 4:36 PM
	Hospital operators anxiously eyeing Walmart - Humana deal seekingalpha.com - April 2 at 12:52 PM

Humana (NYSE:HUM) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement

Humana (NYSE HUM) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff